Our narrowed list of biomarkers may provide optimal targets to tackle pivotal signalling pathways of HCC including the Wnt/β-catenin, TP53, RAS, JAK–STAT, MAPK, the retinoblastoma protein pRb1, oxidative stress and chromatin remodelling pathways [13]. The gene discussed is TP53; the disease is hepatocellular carcinoma.